2018
DOI: 10.18632/oncotarget.25804
|View full text |Cite
|
Sign up to set email alerts
|

Copy number of latent viruses, oncogenicity, and the microcompetition model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…After establishing a latent infection, the viral N-boxes bind and sequester the cellular GABP•p300/CBP transcription complex. Since the p300/CBP coactivator is limiting [33][34][35][36][37], the GABP•p300/CBP transcription complex is limiting. As a result, the sequestering of the complex by the viral promoter/ enhancer decreases the binding of GABP•p300/CBP to cellular genes, specifically, to the BRCA1 gene.…”
Section: Viruses Reduce Available Gabp Via Microcompetitionmentioning
confidence: 99%
“…After establishing a latent infection, the viral N-boxes bind and sequester the cellular GABP•p300/CBP transcription complex. Since the p300/CBP coactivator is limiting [33][34][35][36][37], the GABP•p300/CBP transcription complex is limiting. As a result, the sequestering of the complex by the viral promoter/ enhancer decreases the binding of GABP•p300/CBP to cellular genes, specifically, to the BRCA1 gene.…”
Section: Viruses Reduce Available Gabp Via Microcompetitionmentioning
confidence: 99%